Study of FG-4592 in Subjects With Chronic Kidney Disease in China
Status:
Completed
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
The primary purpose of this study is to evaluate efficacy and safety of FG-4592 in the
correction of anemia in non-dialysis chronic kidney disease patients.